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Abstract 
Background: Intra‑abdominal hypertension (IAH) is frequently present in critically ill patients and is an independent 
predictor for mortality. Better recognition of clinically important thresholds is necessary. Increased intra‑abdominal 
pressure (IAP) is associated with renal dysfunction, and renal failure is one of the most consistently described organ 
dysfunctions associated with IAH. Obesity is also associated with kidney injury. The underlying mechanisms are not 
yet fully understood. Increased IAP may be a link in this association. The aim of this study was firstly to find the range 
in values of intra‑abdominal pressure (IAP) in cardiothoracic surgery patients a secondly to investigate the relation‑
ship between central obesity, body mass index (BMI) and IAP and thirdly to investigate the relationship between IAP, 
inflammation and renal function in this population.
Methods: Consecutive adult patients admitted to the cardiothoracic unit of the intensive care unit (ICU) after 
undergoing elective cardiothoracic surgery were included in this prospective, observational study. C‑reactive protein 
(CRP) as a marker of inflammation and serum creatinine as a marker of renal function were measured pre‑ and post‑
operatively. Estimated glomerular filtration rates were calculated pre‑ and postoperatively. BMI was calculated. Waist 
circumference (WC), hip circumference (HC) and transvesical IAP were measured once directly after admission to the 
ICU postoperatively. Waist/hip ratio (WHR) was calculated (WC divided by HC). Three definitions of central obesity 
were used. Central obesity was defined according to WC, WHR or median WHR.
Results: In total, 186 patients undergoing cardiothoracic surgery were included. Mean IAP was 9.1 mmHg (SD 4.4). 
IAP ≥ 12 mmHg was observed in 50 patients (26.9 %). IAP > 20 mmHg was measured in 4 patients (2.2 %). There 
was a positive correlation between IAP and BMI (r2 = 0.05, p = 0.003). Correlations between IAP and WC (r2 = 0.02, 
p = 0.054) and between IAP and WHR (r2 = 0.01, p = 0.173) were not significant. There were no correlations between 
pre‑ or postoperative CRP and IAP (r2 = 2.3 × 10−4, p = 0.839 and r2 = 0.013, p = 0.117, respectively). In obese 
patients postoperative CRP was significantly higher than in non‑obese patients (p = 0.034). There were no correla‑
tions between pre‑operative serum creatinine and IAP (r2 = 3.3 × 10−5, p = 0.938) or postoperative serum creatinine 
and IAP (r2 = 0.003, p = 0.491).
Conclusions: The range in IAP in patients undergoing cardiothoracic surgery was wide. There was a positive correla‑
tion between IAP and BMI. Correlations between IAP and indices for central obesity were not significant. In a multiple 
regression model BMI was a better predictor of IAP than WHR in this population. There were no correlations between 
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Background
Intra-abdominal hypertension (IAH) is frequently pre-
sent in critically ill patients and is an independent predic-
tor for mortality [1, 2]. Better understanding of the risks 
associated with IAH is necessary, as well as recognizing 
clinically important thresholds [3]. In order to recognize 
clinically important thresholds, we need to improve our 
understanding of the range in intra-abdominal pressure 
(IAP) values. Body mass index (BMI) is positively corre-
lated with baseline IAP [4–9]. The consensus definitions 
published by the World Society of the Abdominal Com-
partment Syndrome (WSACS) state that normal IAP 
is approximately 5–7  mmHg in critically ill adults [10]. 
Baseline levels are higher at approximately 9–14 mmHg 
in morbidly obese patients [11]. These data were derived 
from several studies in a limited amount of patients. A 
possible explanation for higher pressures in the obese is 
that there could be a direct mass effect of the abdominal 
adipose tissue on the measurement of IAP [11]. Epide-
miological studies have shown BMI as an index of general 
obesity, whereas waist circumference (WC) and waist/
hip ratio (WHR) are indices of central obesity [12].
There are few studies describing the relationship 
between central obesity and IAP, and these studies have 
only been conducted in morbidly obese patients under-
going gastric bypass surgery. In a morbidly obese popu-
lation, the IAP correlated with the sagittal abdominal 
diameter, an index of the degree of central obesity [13, 
14]. WHR correlated with IAP in men but not in women 
[14].
In critically ill patients obesity is associated with acute 
kidney injury (AKI) [15]. Central obesity is associated 
with an unfavorable pattern of renal hemodynamic meas-
ures independent of BMI [16]. Multiple mechanisms may 
play a role, but these are not yet fully understood. Inflam-
mation has been postulated to mediate at least part of the 
association between metabolic changes and chronic kid-
ney disease [17]. The kidneys seem to be especially vul-
nerable to dysfunction induced by IAH [18, 19], and renal 
failure is one of the most consistently described organ 
dysfunctions associated with IAH [18, 20]. Increased IAP 
is correlated with renal dysfunction in advanced con-
gestive heart failure, and IAP may be a link to explain 
why patients will eventually end up in dialysis [21]. Fur-
ther data supporting this concept may be obtained by 
demonstrating the association of higher IAP values in 
obese patients in this study.
The aim of this study was firstly to find the range in 
values of IAP after cardiothoracic surgery. Treatment 
both in the operating room and in the intensive care unit 
(ICU) is strictly protocolized for cardiothoracic patients, 
although the indications for surgery may vary. Therefore, 
we measured IAP in patients who were admitted to the 
ICU after undergoing cardiothoracic surgery. The second 
aim was to investigate the relationship between central 
obesity, BMI and IAP in this population. We hypothe-
sized that central obesity may be associated with elevated 
IAP and may be a better predictor of IAP than BMI. The 
third aim was to investigate the relationship between IAP, 
inflammation and renal function.
Methods
Consecutive adult patients admitted to the cardiotho-
racic unit of the ICU after undergoing elective cardiotho-
racic surgery at a tertiary hospital from October 9, 2014, 
to March 31, 2015, were included in this prospective, 
observational study. Exclusion criteria were emergency 
surgery, chronic renal failure or dialysis, pregnancy, age 
<18 years and absence of a urinary bladder.
Waist and hip circumference and IAP were measured 
once directly after admission to the ICU postoperatively. 
BMI was calculated. C-reactive protein (CRP) as a marker 
of inflammation and serum creatinine as a marker of 
renal function were measured pre-operatively and on the 
first postoperative day. Estimated glomerular filtration 
rate (eGFR) was calculated pre- and postoperatively in 
each patient according to the CKD-EPI creatinine equa-
tion [22]. Delta GFR was calculated by subtracting pre-
operative eGFR from postoperative eGFR.
Cardiothoracic surgery patients are routinely intubated 
and deeply sedated by the combination of intravenous 
opiates and continuous infusion of propofol upon post-
operative admission to the ICU, at the time of IAP meas-
urement. All patients were ventilated according to a lung 
protective strategy, including tidal volumes <7  ml/kg. 
Data were collected during the first postoperative admis-
sion only. Major abdominal symptoms were recorded 
during the first 30 postoperative days. Since IAP, CRP 
and serum creatinine measurements are all part of the 
standard care in this ICU, the Medical Ethics Board of 
pre‑ or postoperative CRP and IAP. Furthermore, this study did not find evidence for a relation between IAP and pre‑ 
and postoperative serum creatinine.
Keywords: Intra‑abdominal pressure, Central obesity, Waist/hip ratio, Waist circumference, Body mass index, Renal 
failure, Acute kidney injury
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the University Medical Center Groningen waived formal 
approval and consent (METc 2015/488).
Anthropometric measurements
BMI as a measure of overall obesity was calculated by 
dividing body weight by height squared (kg/m2).
Waist circumference (WC) and hip circumference 
(HC) were measured postoperatively, after an over-
night fast. WC was measured on bare skin, at the natu-
ral indentation between the 10th rib and iliac crest at the 
end of normal expiration to avoid influence of respira-
tion phase on measurements. HC was measured at the 
region of the trochanter major. Values of WC and HC 
were expressed in whole centimeters, and waist/hip ratio 
(WHR) was calculated as WC divided by HC.
Definitions
Normal weight was defined as BMI <25  kg/m2. Over-
weight was defined as BMI between 25 and 29.9 kg/m2, 
while obesity was defined as BMI ≥30 kg/m2 [23, 24].
The non-obese group was defined as both the normal 
weight and the overweight group.
Three definitions of central obesity were used:
1. A WC of ≥102 cm for males and ≥88 cm for females 
[24].
2. A WHR ≥0.90 for males and ≥0.85 for females [24].
3. A WHR > median in the study group [16].
The definition of IAH is a sustained IAP  ≥  12 [10]. 
Abdominal compartment syndrome (ACS) occurs when 
a sustained IAP > 20 is found when associated with new 
organ dysfunction or failure [10]. A major abdominal 
symptom was defined as a consultation by an abdomi-
nal surgeon and/or abdominal surgery within the first 
30 postoperative days. Acute kidney injury (AKI) was 
defined by the RIFLE criteria using pre-operative and 
day 1 postoperative serum creatinine and eGFR levels 
only [25]. Comorbidity was recorded using APACHE IV 
definitions.
Intra‑abdominal pressure
Transvesical IAP was measured according to a stand-
ard protocol using 25  ml of sterile saline as priming 
volume with the symphysis pubis as the zero reference 
point. Patients were in the supine position during IAP 
measurement.
Statistical analysis
IBM SPSS Statistics 22 was used for statistical analysis. 
Descriptive statistics were used. Dichotomous data were 
presented by proportions and continuous data by means 
with standard deviations. Independent Student’s t tests 
were used to calculate the differences between the male 
and female groups and between the non-obese and obese 
groups for continuous data as recorded in Table 1. Chi-
square tests were used to calculate differences between 
the groups for the dichotomous data in Table 1. Mann−
Whitney U tests were used to analyze differences in 
mechanical ventilation duration and length of ICU 
between groups. Paired samples t tests were performed 
to calculate the differences between pre- and postopera-
tive CRP, serum creatinine and between pre- and postop-
erative estimated GFR.
One-way between-group ANOVA was used to calcu-
late the difference in IAP in normal weight, overweight 
and obese patients. Levels of effect size eta squared were 
calculated and interpreted as follows: eta squared 0.01 
small effect, 0.06 medium effect, 0.14 large effect [26]. 
Pearson’s bivariate correlations were used to investigate 
the relationship between central obesity, BMI, IAP, CRP, 
serum creatinine and eGFR. Levels of correlation were 
interpreted as follows:
No correlation r < 0.10 (r2 < 0.01)
Small correlation r = 0.10 to 0.29 (r2 = 0.01 to 0.08)
Medium correlation r = 0.30 to 0.49 (r2 = 0.09 to 0.24)
Large correlation r = 0.50 to 1.0 (r2 = 0.25 to 1) [26]
A standard multiple regression model was used to 
investigate whether BMI or WHR can better predict IAP 
and how much variance in IAP can be explained by val-
ues on these 2 scales.
Results
In total, 186 patients were included, 138 males and 48 
females (Table  1). Data in Table  1 include compari-
sons by gender and by the absence or presence of obe-
sity. All patients had elective surgery, which was most 
often (52  %) a coronary artery bypass grafting (CABG). 
Mean operating time was 245.9  min (SD 88.1  min). In 
117 patients (63  %) extracorporeal circulation was used 
with a mean perfusion time of 149.8 min (SD 71.7 min). 
All patients were mechanically ventilated upon admis-
sion to the ICU. Mechanical ventilation was continued 
for a median of 8 h (range 3–190 h). Most patients (88 %) 
required at least one type of vasoactive medication dur-
ing their stay in the ICU. The median length of stay in 
the ICU was 0.91  days (range 0.4–19.7  days). Missing 
data were recorded in Table 1, when applicable. Figure 1 
shows IAP distribution in this population. IAP values 
ranged from 0 to 26  mmHg. Mean IAP was 9.1  mmHg 
(SD 4.4). IAP ≥  12  mmHg was observed in 50 patients 
(26.9  %); 24 of these patients were overweight and 15 
patients were obese. IAP  >  20  mmHg was measured in 
4 patients (2.2 %); 2 of these patients were obese, and 1 
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Table 1 Patient characteristics
Total number 
of patients
Male Female p value Non‑obese Obese p value
Total number of patients 186 138 (74 %) 48 N/A 148 38 N/A
Male 138 N/A N/A N/A 111 27 N/A
Female 48 N/A N/A N/A 37 11 N/A
Age (years), mean (SD) 64.2 (11.6) 64.2 (10.8) 64.1 (13.5) 0.962 64.4 (12.1) 63.1 (9.3) 0.535
Height (cm), mean (SD) 175.2 (9.9) 179.0 (7.4) 164.3 (7.9) <0.01 175.6 (10.0) 173.5 (9.6) 0.225
Weight (kg), mean (SD) 82.4 (14.1) 86.1 (11.9) 71.9 (14.8) <0.01 78.6 (12.3) 97.4 (10.3) <0.01
BMI (kg/m2), mean (SD) 26.8 (3.8) 26.8 (3.2) 26.6 (5.2) 0.793 25.4 (2.5) 32.4 (2.6) <0.01
WC (cm), mean (SD) 101.9 (10.8) 102.6 (9.7) 99.7 (13.3) 0.168 98.8 (9.4) 113.8 (6.7) <0.01
HC (cm), mean (SD) 106.1 (8.7) 105.3 (7.4) 108.2 (11.5) 0.108 103.5 (6.9) 116.2 (7.6) <0.01
WHR, mean (SD) 0.96 (0.07) 0.97 (0.06) 0.92 (0.07) <0.01 0.95 (0.07) 0.98 (0.06) 0.025
IAP (mmHg), mean (SD) 9.1 (4.4) 9.2 (4.0) 8.6 (5.2) 0.398 8.7 (4.2) 10.4 (4.7) 0.031
IAP ≥ 12 50 40 10 0.086 35 15 0.667
Pre‑operative creatinine (umol/l), mean (SD) 86.0 (19.7) 89.3 (19.5) 76.4 (17.3) <0.01 85.5 (19.4) 87.7 (21.1) 0.546
Pre‑operative CRP (mg/l), mean (SD) 7.3 (13.2) 7.2 (13.3) 7.6 (13.3) 0.884 6.7 (12.8) 9.7 (14.7) 0.211
Pre‑operative eGFR (ml/min/1.73 m2) 78.2 (17.2) 79.6 (16.8) 73.9 (17.8) 0.046 78.5 (17.0) 77.0 (17.9) 0.627
Postoperative creatinine (umol/l), mean (SD) 74.1 (21.8) 77.5 (21.5) 64.4 (19.9) <0.01 73.2 (22.0) 77.9 (21.0) 0.230
Postoperative CRP (mg/l), mean (SD) 49.5 (30.1) 52.2 (31.6) 41.9 (23.8) 0.040 46.5 (26.6) 61.1 (39.0) 0.034
Postoperative eGFR (ml/min/1.73 m2) 88.6 (18.6) 89.2 (18.3) 86.7 (19.8) 0.426 89.4 (18.8) 85.6 (17.8) 0.265
Delta eGFR, mean (SD) (ml/min/1.73 m2) 10.4 (10.2) 9.6 (9.7) 12.8 (11.4) 0.059 10.9 (9.9) 8.6 (11.4) 0.223
Comorbidity 
Chronic diagnosis at admission ICU
 COPD 17 13 4 N/A 14 3 N/A
 Chronic cardiovascular insufficiency 10 8 2 N/A 8 2 N/A
 Immunological insufficiency 8 6 2 N/A 4 4 N/A
 Metastasized neoplasm 3 2 1 N/A 2 1 N/A
 Respiratory insufficiency 1 1 0 N/A 1 0 N/A
 Hemotological malignancy 1 1 0 N/A 1 0 N/A
Diagnosis at admission ICU
 Cardiovascular resuscitation 1 1 0 N/A 1 0 N/A
 Dysrhythmia 2 1 1 N/A 2 0 N/A
 Mechanical ventilation at admission 186 138 48 N/A 148 38 N/A
 Diabetes 21 12 9 0.103 11 10 0.003
 Myocardial infarction 40 34 6 0.119 32 8 1.0
Diagnosis 24 h after ICU admission
 Acute kidney injury 1 1 0 N/A 1 0 N/A
 Confirmed infection 1 1 0 N/A 1 0 N/A
 Vasoactive medication in first 24 h 164 119 45 0.259 132 32 0.571
 Apache IV score, mean (SD) N = 184 42.8 (13.8) 41.8 (15.0) 43.7 (12.5) 0.435 42.0 (15.3) 43.4 (10.1) 0.521
 Euro score, mean (SD) 7.1 (7.6) 6.4 (7.4) 8.9 (7.9) 0.050 7.6 (8.1) 5.2 (4.7) 0.024
Surgery
 CABG 97 80 17 N/A 74 23 N/A
 CABG + valve 16 9 7 N/A 13 3 N/A
 Valve 58 40 18 N/A 49 9 N/A
 Aneurysm—thoracic aortic repair 9 5 4 N/A 8 1 N/A
 Othera 6 4 2 N/A 4 2 N/A
Operating time (min), mean (SD)
 N = 179 245.9 (88.1) 247.7 (92.1) 240.7 (76.0) 0.642 240.9 (80.1) 265.1 (113.1) 0.138
Perfusion time (min), mean (SD)
 N = 117 149.8 (71.7) 151.4 (78.0) 146.0 (55.9) 0.707 143.7 (64.5) 177.6 (95.4) 0.049
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was overweight. Three patients (1.6 %) developed major 
abdominal symptoms during the first 30 days postopera-
tively. These 3 patients all had an IAP < 12 mmHg. One 
patient had a perforation of a Zenker’s diverticulum due 
to perioperative placement of a gastric tube, 1 patient 
had coprostasis, and 1 patient had abdominal pain due to 
pneumonia. Management was conservative in all cases.
Table  1 shows that IAP is significantly higher in the 
obese group when compared with the non-obese group. 
Mean IAP was 10.4 mmHg (SD 4.7) in the obese group 
and 8.7 mmHg (SD 4.2 mmHg) in the non-obese group 
(p = 0.031). Figure 2 shows IAP distribution dependent 
on definition. Firstly IAP distributions versus BMI are 
shown in Fig. 2a. Mean BMI was 26.8 kg/m2 (SD 3.8). In 
total, 87 patients were overweight and 38 patients were 
obese. Mean IAP was different between different weight 
groups (p  =  0.029). In the normal weight group mean 
IAP was 8.1  mmHg (SD 4.6), in the overweight group 
9.2 mmHg (SD 3.9) and in the obese group 10.4 mmHg 
(SD 4.7). Firstly, there was a significant difference 
between the obese group and the other two groups 
(p =  0.023) and secondly there was a significant differ-
ence when the obese group was compared to the normal 
weight group (p  =  0.008). The difference in mean IAP 
between the groups was small. The effect size was small 
(eta squared = 0.04).
In Fig.  2b–d IAP distribution is shown when central 
obesity is absent or present according to the definitions 
1–3 of central obesity. The number of patients with cen-
tral obesity varied according to which definition was 
used. If central obesity was defined according to WC 
(definition 1), there were 111 patients (59.7 %) with cen-
tral obesity in this population. Mean IAP was 8.9 (SD 4.4) 
when central obesity was absent and 9.2 (SD 4.3) when 
central obesity was present (p = 0.687). Both groups had 
a median IAP of 8.0 mmHg.
If central obesity was defined according to WHR (defi-
nition 2), there were 168 patients (90.3  %) with central 
obesity in this population. Using this definition, mean 
IAP was 7.7  mmHg (SD 4.2) when central obesity was 
absent and 9.2 mmHg (SD 4.4) when central obesity was 
present (p = 0.171).
If central obesity was defined according to median 
WHR (=0.96) (definition 3), there were 93 patients (50 %) 
with central obesity in this population. Using this defi-
nition, mean IAP was 8.9 mmHg (SD 4.4) when central 
obesity was absent and 9.3  mmHg (SD 4.3) when cen-
tral obesity was present (p = 0.503). Although there was 
a trend toward a higher mean IAP in central obesity, 
regardless of which definition was used, this was not sta-
tistically significant.
There was a positive correlation between IAP and 
BMI (r2 =  0.05, p =  0.003). Correlations between IAP 




Male Female p value Non‑obese Obese p value
Aorta occlusion time (min), mean (SD)
 N = 101 104.9 (49.0) 106.4 (53.3) 101.7 (38.7) 0.656 102.2 (45.7) 116.5 (61.4) 0.255
ICU
 Mechanical ventilation duration in hours, 
median (range)
8.0 (187) 7.0 (187) 8.0 (91) 0.402 8.0 (187) 8.0 (85) 0.335
 Reintubation within 72 h after detubation 0 0 0 N/A 0 0 N/A
 Length of stay ICU in days, median (range) 0.91 (19.4) 0.91 (19.4) 0.92 (6.1) 0.588 0.91 (19.4) 0.94 (5.2) 0.060
p < 0.05 is significant
N/A not applicable
a Includes pericardiectomy, congenital defect repair and ablation
Fig. 1 Histogram showing IAP distribution
Page 6 of 10Smit et al. Ann. Intensive Care  (2016) 6:99 
WHR (r2 = 0.01, p = 0.173) were not significant (Fig. 3). 
A multiple regression model where BMI and WHR 
were analyzed as predictors of IAP showed that BMI 
and WHR together explained 5 % of the variance in IAP 
(p  =  0.009). BMI made a significant unique contribu-
tion to IAP (Beta 0.208, p =  0.006) which was greater 
than the unique contribution of WHR (Beta 0.043, 
p = 0.569). Hence, BMI is a better predictor of IAP than 
WHR.
Additional file  1: Figure  S1 shows IAP distribution in 
non-obese and obese patients.
There was no correlation between IAP and operating 
time (r2 =  0.006, p =  0.320). Correlations between IAP 
and perfusion time (r2 =  0.01, p =  0.268) and between 
IAP and aorta occlusion time (r2 = 0.01, p = 0.278) were 
not significant (Additional file  2: Figure  S2). Mean IAP 
in patients with extracorporeal perfusion was 9.0 mmHg 
(SD 4.3) and without extracorporeal perfusion 9.2 mmHg 
(SD 4.4) (p = 0.741).
Mean CRP was 7.3  mg/l (SD 13.2) pre-operatively. 
It increased to a mean of 49.5 mg/L (SD 30.1, p < 0.05) 
on the first postoperative day. There was no correlation 
between pre- or postoperative CRP and IAP (pre-opera-
tive r2 = 2.3 × 10−4, p = 0.839; postoperative r2 = 0.013, 
p =  0.117) (Table  2). Postoperative CRP was correlated 
with BMI, WC and WHR (Table 2), and in obese patients 
postoperative CRP was significantly higher than in non-
obese patients (p = 0.034) (Table 1).
Fig. 2 IAP distribution dependent on definition. a IAP distribution according to BMI. b IAP distribution according to WC. c IAP distribution accord‑
ing to WHR. d IAP distribution according to median WHR
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Mean serum creatinine pre-operatively was 86.0 umol/l 
(SD 19.7) and decreased postoperatively to 74.1 umol/l 
(SD 21.8, p < 0.05).
Mean eGFR pre-operatively was 78.2 (SD 17.2) and 
increased postoperatively to 88.6  ml/min/1.73  m2 (SD 
18.6, p  <  0.05). There was no correlation between pre-
operative serum creatinine and IAP (r2  =  3.3  ×  10−5 
(p  =  0.938)) or postoperative serum creatinine and 
IAP (r2  =  0.003 (p  =  0.491)) (Table  2). Correlations 
between pre- and postoperative eGFR and IAP were 
r2  =  4.35  ×  10−4 (p  =  0.780) and r2  =  5.4  ×  10−4 
(p  =  0.753), respectively. There were small correlations 
between postoperative serum creatinine and BMI, WC 
and WHR (Table  2). One patient developed acute kid-
ney injury. According to the RIFLE criteria this patient is 
included in the risk category, with an increase in serum 
creatinine from 68 to 121 μmol/l and a 44 % decrease in 
eGFR. This male patient had a BMI of 29.4 kg/m2 and an 
IAP of 5 mmHg.
A subgroup analysis shows that in males with central 
obesity, defined by WHR, IAP was significantly higher 
than in males without central obesity (Additional file  3: 
Figure S3). Additional file 4: Figure S4 shows a flowchart 
of this study
Fig. 3 a Correlation between IAP and BMI. b Correlation between IAP and WC. c Correlation between IAP and WHR
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Discussion
This study shows a wide range in IAP in patients under-
going elective cardiothoracic surgery, between 0 and 
26  mmHg. A single IAP measurement was elevated 
≥12  mmHg in more than 26  % of patients. Further-
more, an IAP  >  20  mmHg was measured in 4 patients. 
We found a correlation between BMI and IAP. We did 
not find that other definitions of body shape correlated 
better with IAP than BMI. We did not find a correlation 
between CRP or serum creatinine and IAP. However, 
postoperative CRP and postoperative serum creatinine 
are correlated with BMI, WC and WHR.
The large variation in IAP shows that a single measure-
ment of IAP should be interpreted with caution. Ulti-
mately, the clinical context gives meaning to an increased 
IAP and repeated measurements should be performed 
before a diagnosis of IAH or ACS can be made.
Most patients were either overweight or obese. The 
high proportion of obesity in this cardiothoracic sur-
gery population is not surprising, considering obesity is 
a risk factor for cardiovascular conditions. Mean IAP in 
the obese group was significantly higher than in the non-
obese group. However, despite reaching statistical sig-
nificance, the actual difference in mean scores between 
the groups was small. Furthermore, BMI is a better pre-
dictor of IAP than WHR, but BMI and WHR together 
explained only 5 % of the variance in IAP. This means that 
in an obese patient with clinical symptoms of ACS an 
increased IAP should never be attributed to obesity only. 
There is no evidence that an obesity-related elevation in 
IAP is not a true ACS, but only a direct mass effect of the 
visceral obesity [13].
At least 50 % of patients in this study have central obe-
sity. The exact number of patients with central obesity 
varies according to which definition is used. Although 
there was a trend toward a higher mean IAP in central 
obesity according to these definitions, this was not statis-
tically significant. Even though there seemed to be a posi-
tive correlation between IAP and WC and between IAP 
and WHR, this was not statistically significant. Hence, 
this study does not match with findings from previous 
studies in the morbidly obese [13, 14]. We believe that 
this study may have been underpowered to show these 
relations. We did not find a correlation between IAP and 
inflammation or between IAP and renal function in this 
population. Future studies should consider using more 
sensitive biomarkers for determination of both systemic 
inflammation and renal function and take into account 
that larger datasets may be required to find relations.
We did find a correlation between postoperative CRP 
and postoperative serum creatinine and BMI, WC and 
WHR. This matches with findings in a larger group 
of otherwise healthy persons, where the correlation 
between renal function and body shape was also shown 
[16].
A subgroup analysis shows that in males with central 
obesity, defined by WHR, IAP was significantly higher 
than in males without central obesity. This difference was 
not found in females. This matches with findings in the 
morbidly obese, where WHR was correlated with transves-
ical IAP in men but not in women [14]. A possible expla-
nation may be the difference in abdominal compliance 
between males and females. In patients with a decreased 
abdominal compliance, the same change in intra-abdom-
inal volume will result in a greater change in IAP. Cen-
tral obesity usually results in increased visceral fat and a 
sphere-like baseline shape of the abdominal cavity with 
poor stretching capacity, whereas in peripheral obesity the 
internal abdominal diameter is shaped as an ellipse and 
has a huge stretching capacity (and thus higher abdomi-
nal compliance) [27]. Factors associated with decreased 
abdominal compliance include male gender and (central) 
obesity. Factors associated with increased abdominal com-
pliance include female gender, peripheral obesity, previous 
pregnancy and previous abdominal surgery [28].
We assumed that the patients in this study did not have 
an increased risk for development of IAH or ACS. How-
ever, there is one study in 25 patients which concludes 
that the CABG procedure with extracorporeal circulation 
may result in increased intra-abdominal pressure due to 
the invoked inflammatory response by the extracorpor-
eal circulation [29]. Operating time, perfusion time and 
Table 2 Correlations of pre- and postoperative CRP, serum creatinine and eGFR and IAP, BMI, WC and WHR
p < 0.05 is significant
IAP r2 p BMI r2 p WC r2 p WHR r2 p
Pre‑operative CRP 2.3 × 10−4 0.839 0.018 0.071 0.004 0.418 0.002 0.582
Postoperative CRP 0.013 0.117 0.052 0.002 0.034 0.012 0.055 0.001
Pre‑operative serum creatinine 3.3 × 10−5 0.938 0.009 0.205 0.009 0.193 0.024 0.033
Postoperative serum creatinine 0.003 0.491 0.025 0.030 0.025 0.031 0.038 0.008
Pre‑operative eGFR 4.3 × 10−4 0.780 0.006 0.275 0.015 0.097 0.003 0.435
Postoperative eGFR 5.4 × 10−4 0.753 0.019 0.062 0.035 0.011 0.015 0.092
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aorta occlusion time were not correlated with IAP in the 
present study. Furthermore, there was no difference in 
mean IAP in patients with and without extracorporeal 
circulation. Therefore, the findings in our study do not 
corroborate Dabrowski’s conclusions.
These results raise the question whether the elevations 
in IAP measured in this study are pathological. Since IAP 
was measured only once, a diagnosis of IAH or ACS could 
by definition not be made. Furthermore, only 3 patients 
developed abdominal symptoms during their stay in the 
ICU; none of these patients had an IAP ≥ 12  mmHg 
upon admission. However, higher IAP values were found 
in obese patients and we have to consider that the IAP 
in obese patients is chronically increased. Even slight 
elevations in IAP are associated with increased systemic 
inflammation, and signs of acute kidney injury [19] and 
weight excess and/or central body fat distribution are 
associated with increased long-term renal risk [30]. Obe-
sity is associated with acute kidney injury in critically ill 
patients [15], and this study shows a correlation between 
postoperative serum creatinine and BMI, WC and WHR. 
IAP is probably only one of many contributing factors to 
renal function, and it will be hard to dissect consequences 
of a slight chronic increase in IAP from other factors 
related to renal function loss [31]. In contrast to acute 
models of ACS, there are no models of small long-term 
increases in IAP.
Since IAP  >  12 independently predicts organ fail-
ure and mortality in a mixed population of critically ill 
patients [1, 2], perhaps we should monitor IAP more 
closely in overweight and obese patients when they are 
critically ill, in order to avoid any further increase in IAP.
Limitations of this study
This study was performed in a selected population of 
elective cardiothoracic surgery patients. Moreover, other 
anthropomorphic parameters like sagittal abdominal 
diameter were not measured in this study.
IAP was measured only once per patient; there-
fore, a diagnosis of IAH (sustained or repeated IAP ≥ 
12 mmHg) or ACS (sustained or repeated IAP > 20 with 
new organ failure) could not be made. Furthermore, 
IAP was measured postoperatively and this measure-
ment could have been influenced by perioperative fluid 
management.
CRP was measured as a marker of inflammation, and 
serum creatinine was measured as a marker of renal func-
tion; however, these markers lack specificity and sensitivity 
to determine subtle differences in inflammation and renal 
function. This study may have been underpowered to show 
a relation between body shape and IAP, CRP and serum 
creatinine. Sensitive AKI biomarkers, such as neutrophil 
gelatinase-associated lipocalin (NGAL) and cystatin C, 
may reveal the relation between IAP and renal function in 
future studies with larger datasets.
Conclusions
The range in IAP in patients undergoing cardiotho-
racic surgery was wide. There was a positive correla-
tion between IAP and BMI. Correlations between IAP 
and indices for central obesity were not significant. In 
a multiple regression model BMI was a better predic-
tor of IAP than WHR in this population. There were no 
correlations between pre- and postoperative CRP and 
IAP. Furthermore, this study did not find evidence for a 
relation between IAP and pre- and postoperative serum 
creatinine.
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